Le Mesnil-Esnard, France

Marc Venet Gaston


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide information on inventor Marc Venet Gaston based on the given data.

Title:

Exploring the Innovations of Marc Venet Gaston: Transforming Medicine Through Metabotropic Glutamate Receptor Antagonists

Introduction:

Marc Venet Gaston, a talented inventor hailing from Le Mesnil-Esnard, France, has made significant contributions to the field of medicine with his groundbreaking patent on Metabotropic glutamate receptor antagonists. His innovation has the potential to revolutionize the treatment of glutamate-induced diseases of the central nervous system.

Latest Patents:

Marc Venet Gaston holds a remarkable total of 1 patent, focusing on compounds of formula that have shown promising results in treating and preventing central nervous system disorders related to glutamate.

Career Highlights:

Currently affiliated with Janssen Pharmaceutica Nv, Marc Venet Gaston continues to drive innovation in the pharmaceutical industry. His dedication to research and development has placed him at the forefront of medical advancements.

Collaborations:

Throughout his career, Marc Venet Gaston has collaborated closely with esteemed colleagues such as Dominique Jean-Pierre Mabire and Sophie Philippe Coupa. Together, they have worked tirelessly to bring cutting-edge solutions to the field of medicine.

Conclusion:

In conclusion, Marc Venet Gaston's pioneering work in the development of Metabotropic glutamate receptor antagonists stands as a testament to his ingenuity and commitment to improving healthcare. His contributions have the potential to enhance the lives of individuals suffering from central nervous system disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…